Home›Companies›Biotech & Pharma›Georgiamune

Georgiamune, Inc.

Develops immune-based drugs for people with cancer and autoimmune diseases.

Updated Nov 9, 2026·Latest SEC filing Aug 17, 2026·Suggest an edit

About Georgiamune

Georgiamune is a private company based in Gaithersburg, Maryland. It has reported $92,692,709 raised in one offering on Form D since August 2026. Its chief executive is Paul Brown.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 16, 2026Aug 17, 2026$92,692,709of $131.8M target26$3.5MEquity, Series B Preferred StockRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Georgiamune's Form D filed Aug 17, 2026.

Sean Parker
Sean Parker
Chairman, Parker Institute for Cancer Immunotherapy
EV
Elena Viboch
Director
Paul Brown
Paul Brown
Cofounder, CEO, Inspire Brand and director
NO
Samir Khleif
Samir Khleif
Founder/President/Chief Executive Officer and director
Amy Abernethy
Amy Abernethy
Cofounder, Highlander Health and director

Sources

  1. SECGeorgiamune, Inc. filing history
  2. CompanyGeorgiamune team